RxDoctor Payments Data

Stuart Style, DO

Family Medicine · Voorhees, NJNPI 1538153523

Payments from drug & device makers

$1,607in general payments, 2019–2025

Across 116 payments — averaging $13.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$386
  • Kowa Pharmaceuticals America, Inc.$201
  • Exact Sciences$142
  • AstraZeneca$116
  • Lilly USA, LLC$114
  • Pfizer$112
  • plus $536 from 13 others

What the payments were for

  • Food & beverage$1,607100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,607 in reported general payments places this provider in the 70th percentile of 2,084 family medicine providers in New Jersey.

See all family medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$89,154
Medicare patients
448
Services billed
1,161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban82$73,067
JardianceEmpagliflozin36$32,830
JanuviaSitagliptin Phosphate33$23,655
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$22,944
JanumetSitagliptin Phos/Metformin Hcl16$13,811
Breo ElliptaFluticasone/Vilanterol26$10,244
Atorvastatin Calcium410$5,162
MyrbetriqMirabegron12$5,087
Incruse ElliptaUmeclidinium Bromide13$4,927
Epinephrine12$4,236
Amlodipine-AtorvastatinAmlodipine/Atorvastatin16$4,169
Albuterol Sulfate HfaAlbuterol Sulfate144$4,083
Losartan Potassium303$3,729
Amlodipine Besylate706$3,687
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$3,399

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$112$73,06782 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$386$38,11565 claims
MerckJanuvia, Janumet$80$37,46649 claims
Boehringer IngelheimJardiance$62$32,83036 claims
Astellas Pharma US IncMyrbetriq$74$5,08712 claims
AbbVieSynthroid$33$2,05133 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,084 family medicine providers in New Jersey.

Other family medicine in Voorhees

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →